09:59 AM EST - Valeant Pharmaceuticals International, Inc. : Announced its third-quarter 2017 financial results. Revenues were $2,219 million. GAAP Net Income was $1,301 million. Adjusted net income (non-GAAP) was $367 million. Valeant Pharmaceuticals International, Inc.
shares T.VRX are trading up $2.65 at $18.08.
